Multiple Sclerosis and the Pathogenicity of Mir-155

Abstract

Multiple sclerosis (MS) is one of the complex diseases. Genetics, environmental and emotional factors have shown to play essential roles in evoking the disease pathology. More interestingly, epigenetic factors were established as major influencers of the disease severity [1] Of those epigenetic factors; the microRNA (miRNA) plays a fundamental function in MS pathogenicity. MiRNA are small noncoding RNA molecules with a size of approximately 22 nucleotides involved in post-transcriptional regulations of the genes [2-5]. In one of the first published papers on the relation between MS and miRNA, Otaegui and his group found differential miRNA profile between MS patient and healthy volunteers when analyzing 364 peripheral blood mononuclear cells (PBMC) samples. More so, they found that even between MS patients, miRNA profile can differentiate between remissions and relapses stages [6]. One of the most attractive miRNA associated with MS was the miR-155. In 2009, Junker et al have for the first time identified miR-155 upregulation in active MS lesions [7]. Subsequently, many have established the role of this miRNA in relapsing stages of MS and experimental autoimmune encephalomyelitis (EAE) [4,8-15]. MiR-155 was of interest due to its important roles in immune system regulation. This miRNA has been proven to target the suppressor of cytokine signaling -1 (SOSC1); a negative regulator of cytokines signaling. It was also proven to induce T- cell differentiation along the T-helper 17 (Th17) and T-helper 1 (Th1) cells lines [16- 19]. MiR-155 was, moreover, documented to target transcription factor Ets1; a negative modulator of Th17 differentiation [20]. Additionally, it targets CD47; a molecule involved in self-recognition and protect cells from phagocytosis [21]. It, more so, suppresses src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1); a known negative inhibitor of pro-inflammatory pathways to macrophages (MØ) and dendritic cells (DCs) [20]. Besides all that, miR-155 can suppress essential neuro-steroids in the white matter of MS cases [21,22]. And was noted to increase the tumor necrosis factor - α (TNFα) and monocyte chemoattractant protein-1 (MCP1) expression in a toll-like receptor -4 (TLR4)-dependent manner, resulting in neuro-inflammation in the cerebellum [23].

Authors and Affiliations

Eiman MA Mohammed

Keywords

Related Articles

A Case Study: Polychlorinated Dibenzo-p-dioxins, Polyclorinated Dibenzofurans, Polychlorinated biphenyls, and Polybrominated diphenyl ethers in the bone marrow and lymph nodes of adult reindeer (Rangifer tarandustarandus L.) hind in Finland

It is typical for POPs that they are transported long distances from source to sink areas. Reindeer (Rangifer tarandustarandus L.) is considered to be one of the most important indicator species for environmental toxic c...

An Unusual Case of Statin-Related Myopathy

A 68 year male patient (KB) presented in August 2014 with profound muscle weakness of the hip and legs. Treatment with an 8 cycle regimen of CHOP for NHL 10 years earlier led to complete remission. He had also been treat...

Olanzapine-Induced Cirrhosis and Hepatocellular Carcinoma by Hepatotoxicity in An Elder Chinese Woman: Case Report and Review of The Literature

Olanzapine is an atypical antipsychotic that is used currently in the treatment of schizophrenia and bipolar illness, we present a case of a 75-year-old Chinese woman with schizophrenia for 30 years who used a long-term...

One Possible Cause of the Recent Increase in “Fraudulent” Research

Recently, some disturbing news has shaken the scientific research community. This news reported a decline in the accuracy of research data and the more frequent appearance of wrong or even falsified research results. A s...

Prospects for Improving the Effectiveness of Chemotherapy in Patients with Tumors

Despite the intensive efforts of researchers, the area of anti-tumor therapy still contains number of unsolved problems. Among the most general ones are: late diagnosis, poor efficiency of available therapies, multiple s...

Download PDF file
  • EP ID EP591795
  • DOI 10.26717/BJSTR.2018.09.001841
  • Views 165
  • Downloads 0

How To Cite

Eiman MA Mohammed (2018). Multiple Sclerosis and the Pathogenicity of Mir-155. Biomedical Journal of Scientific & Technical Research (BJSTR), 9(4), 7316-7319. https://europub.co.uk/articles/-A-591795